Walden University

ScholarWorks
Walden Dissertations and Doctoral Studies

Walden Dissertations and Doctoral Studies
Collection

2020

Levels of Albuterol Inhaler With and Without Spacers in Children
With Asthma
Jefferson Libed Pambid
Walden University

Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Public Health Education and Promotion Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies
Collection at ScholarWorks. It has been accepted for inclusion in Walden Dissertations and Doctoral Studies by an
authorized administrator of ScholarWorks. For more information, please contact ScholarWorks@waldenu.edu.

Walden University
College of Health Sciences

This is to certify that the doctoral study by

Jefferson Libed Pambid

has been found to be complete and satisfactory in all respects,
and that any and all revisions required by
the review committee have been made.

Review Committee
Dr. Mountasser Kadrie, Committee Chairperson, Public Health Faculty
Dr. W. Sumner Davis, Committee Member, Public Health Faculty
Dr. Stacey-Ann Christian, University Reviewer, Public Health Faculty

Chief Academic Officer and Provost
Sue Subocz, Ph.D.

Walden University
2020

Abstract
Levels of Albuterol Inhaler With and Without Spacers in Children With Asthma
by
Jefferson Pambid

MPH, National University, 2017
BS, National University, 2015
AA, Southwestern College, 2013

Doctoral Study Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Public Health

Walden University
November 2020

Abstract
Children with asthma remain a problem in public health because asthma drastically
impacts children’s daily activities, increases absenteeism in school, and causes
difficulties in sleeping. Researchers have demonstrated that poor asthma management is
due to a lack of education about the correct inhaler technique, and the appropriate doses
are not inhaled. Researchers have yet established whether asthma symptoms improve
based on the doses inhaled with or without a spacer and whether children are most likely
to experience fewer asthma episodes or attacks if they receive professional instruction.
The purpose of this study was to fully understand the influence of an inhalation device
with or without a spacer in medication delivery and to understand if instruction given by
clinicians alleviates the number of asthma episodes or attacks. The transtheoretical or
stages of change was used to analyze an individual’s ability to act on a new healthier
behavior. This study involved children (N = 416) aged 7 through 12 years old who
participated in the 2015 Asthma Call-Back Survey. Quantitative cross-sectional study
design was used to encompass information, including an interview questionnaire, a
survey, and existing literature. A chi-square, Phi, and Cramer’s V test were used to
address the research questions. The results of this study indicated that managing asthma
symptoms does not depend on the number of doses inhaled with or without a spacer.
Children are less likely to experience asthma episodes or attacks with proper professional
education. Further exploration is needed to investigate the effectiveness of the method of
teaching by pharmacists and other clinicians. The parents of children and clinicians may
benefit from the results of this study by taking immediate health improvement action.

Levels of Albuterol Inhaler With and Without Spacers in Children With Asthma
by
Jefferson Pambid

MPH, National University, 2017
BS, National University, 2015
AA, Southwestern College, 2013

Doctoral Study Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Public Health

Walden University
November 2020

Dedication
I dedicate my doctoral study to my family. My family has been my inspiration to
obtain higher education and do great things in life. I am grateful for my family for their
endless support in my studies and professional goals. I could not have reached another
milestone without them by my side.

Acknowledgments
I would like to thank my committee members, Dr. Mountasser Kadrie and Dr. W
Summer Davis, for their full support and endless commitment to review and provide
feedback on my doctoral study. I thank you for encouraging me to do better academically
and professionally. I also would like to thank my URR, Dr. Stacy-Ann Christian, for
providing important insights and feedback on my doctoral study.

Table of Contents
List of Tables ..................................................................................................................... iv
List of Figures ......................................................................................................................v
Section 1: Foundation of the Study and Literature Review .................................................1
Introduction ....................................................................................................................1
Problem Statement .........................................................................................................2
Purpose of the Study ......................................................................................................4
Research Questions and Hypotheses .............................................................................4
Theoretical Foundation for the Study ............................................................................5
Nature of the Study ........................................................................................................7
Literature Search Strategy..............................................................................................8
Literature Review Related to Key Variables and/or Concepts ......................................8
Health Issue: Asthma .............................................................................................. 8
Quality of Life for Children With Asthma ............................................................. 9
Emergency Department Visit ................................................................................ 10
Inhaler Device ....................................................................................................... 12
Asthma Education ................................................................................................. 14
Spacers .................................................................................................................. 16
Definitions....................................................................................................................19
Assumptions.................................................................................................................21
Scope and Delimitations ..............................................................................................22
Scope of the Study ................................................................................................ 22
i

Delimitations ......................................................................................................... 22
Significance..................................................................................................................22
Summary ......................................................................................................................23
Conclusion ...................................................................................................................24
Section 2: Research Design and Data Collection ..............................................................26
Introduction ..................................................................................................................26
Research Design and Rationale ...................................................................................26
Methodology ................................................................................................................27
Population ............................................................................................................. 27
Sampling and Sampling Procedures ..................................................................... 27
Data Collection ..................................................................................................... 29
Inclusion Criteria .................................................................................................. 29
Exclusion Criteria ................................................................................................. 30
Power Analysis ..................................................................................................... 30
Instrumentation and Operationalization of Constructs ......................................... 31
Operationalization ................................................................................................. 31
Data Analysis Plan ................................................................................................ 33
Statistical Analysis ................................................................................................ 34
Threats to Validity .......................................................................................................35
Ethical Procedures .......................................................................................................36
Summary ......................................................................................................................37
Section 3: Presentation of the Results and Findings ..........................................................38
ii

Introduction ..................................................................................................................38
Data Collection of Secondary Data Set .......................................................................39
Timeframe for Data Collection ............................................................................. 39
Response Rate ....................................................................................................... 40
Demographic Characteristics of the Sample ......................................................... 40
Results of the Study .....................................................................................................42
Statistical Assumptions ................................................................................................42
Summary ......................................................................................................................55
Section 4: Application to Professional Practice and Implications for Social
Change ...................................................................................................................56
Introduction ..................................................................................................................56
Interpretation of the Findings.......................................................................................56
Application of Transtheoretical Change or Stages of Change .....................................59
Limitations of the Study...............................................................................................59
Recommendations ........................................................................................................60
Implications for Professional Practice and Social Change ..........................................61
Professional Practice ............................................................................................. 61
Social Change ....................................................................................................... 62
Conclusion ...................................................................................................................63
References ..........................................................................................................................65

iii

List of Tables
Table 1. Dependent Variables .......................................................................................... 32
Table 2. Independent Variables ....................................................................................... 32
Table 3. State of Child ..................................................................................................... 41
Table 4. Child Age Age-Group Call-Back ...................................................................... 41
Table 5. Gender of Child ................................................................................................. 41
Table 6. Albuterol (+ A. Sulfate or Salbutamol) Medication With or Without a Spacer . 45
Table 7. Chi-Square Tests ................................................................................................ 47
Table 8. Symmetric Measures.......................................................................................... 47
Table 9. The Number of Episodes or Attacks and Professional Inhaler Instruction......... 51
Table 10. Chi-Square Tests ............................................................................................... 54
Table 11. Symmetric Measures......................................................................................... 54

iv

List of Figures
Figure 1. The number of canisters inhaled whether spacer used among children aged
seven to 12 years old. ................................................................................................ 46
Figure 2. The number of asthma episodes or attacks whether a professional inhaler
instruction provided .................................................................................................. 53

v

1
Section 1: Foundation of the Study and Literature Review
Introduction
Children with asthma may encounter serious health complications that may affect
their health status, which has become a significant concern in public health. Asthma
causes inflammation in the airways, resulting in difficulty breathing, wheezing, and
shortness of breath. Asthma is frequently associated with respiratory infections, chest
pressure, anxiety, rapid heart rate, and throat irritation (Denholm, Van Der Werf, & Hay,
2020; Ehrlich et al., 2019). In the United States, more than 497,000 people are
hospitalized annually due to asthma (Shaw et al., 2016), and according to the Centers for
Disease Control and Prevention (CDC; 2018), there are over 6 million children under the
age of 18 with asthma. The use of inhaled treatments has become one standard protocol
for asthma and children (Bush, Fleming, & Saglani, 2017); however, this remains a
concern as proper usage and effectiveness of this form of treatment may not always be
performed correctly.
While the inhalation of medication remains a standard treatment, the inclusion of
a spacer helps prevent medication loss, ensuring more of the treatment is inhaled to the
lungs (Gillette, Rockich-Winston, Kuhn, Flesher, and Shepherd, 2016). A spacer is a tube
that improves the inhalation of medication into the lungs (Kofman & Teper, 2018).
Moreover, children who lack training in the proper use of the inhaler may not receive
sufficient treatment, resulting in significantly limited asthma symptom control. The
technique used in the inhalation of medication determines the amount of medication
delivered to the lungs; operating the inhaler device correctly increases the likelihood of
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receiving the proper therapeutic dose. Therefore, further study is needed to investigate the
association between (a) the amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled
(with or without spacers) among children in the sample population, (b) the association
between education on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol), and
(c) the severity of asthma attacks in children.
This study can promote positive social change because the results help inform the
foundational knowledge by informing parents about the proper use of inhalation and
making appropriate health decisions to reduce asthma incidents in children. Public health
professionals and other clinical providers could use the research findings to educate the
parents to increase awareness of this health issue. Positive social change may be
accomplished through health care providers demonstrating the proper use of the
inhalation technique while administering the medication on their patients in the
healthcare setting. Effectively using the inhalation devices properly with a spacer may
significantly alleviate the duration of asthma episodes and reduce emergency department
(ED) visits.
Problem Statement
Asthma remains a significant concern in the field of public health because it
drastically impacts children’s daily activities, increases absenteeism in school, and causes
difficulties in sleeping (Shaikh & Byrd, 2016). In the United States, an estimated 10% of
children have asthma (Shaikh & Byrd, 2016); if left untreated, asthma symptoms can be
worsened through poor symptom management, leading to severe health conditions. An
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inhaler remains the standard method for delivering asthma medication into the lungs
(Gillette et al., 2016).
Research has shown that some children’s inhaler techniques might be ineffectual,
and the type of device used might affect asthma outcomes (Gillette et al., 2016). Incorrect
inhalation technique is a significant factor for inadequate medication delivery, resulting
in poor control of asthma symptoms (Ravikumar, Raghavendra, & Priyadarshini, 2018).
Therefore, establishing an efficient method is crucial in selecting asthma control
medication delivery (Gillette et al., 2016). According to Kofman and Teper (2018),
improving the inhalation technique, such as using a spacer with inhalation delivery
devices, increases asthma control in children. As researchers have yet to investigate if a
certain amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without a spacer
affects the likelihood of asthma episodes or attacks in children between the ages of 7 and
12, there currently exists a gap in the knowledge.
Inhalation of medications has several positive effects in treating diseases of the
respiratory tract (Kofman & Teper, 2018). When using the inhalation devices, patients
need to follow several chronological steps to deliver the drugs successfully to the lungs
(Al Ammari, Yunus, Al Ghobain, & Al Halwan, 2016). Many children with asthma
misuse their inhaler devices, resulting in unreliable drug delivery, even after proper
inhalation instruction (Jat, Singhal, & Guglani, 2016). Many children still misuse their
inhaler device, even after being taught how to operate the device correctly (Shaw et al.,
2016). Özkars and Kirik (2019) added that an improper medication use technique could
prevent the medication from reaching airways, resulting in at least limited effectiveness
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in treating symptoms. Children’s inhalation techniques may be too imprecise to result in
reliable drug delivery (Shaw et al., 2016). Consequently, in this study, I focused on
investigating the association between the amounts of inhalation of Albuterol (+ A. Sulfate
or Salbutamol) with and without spacers in children ages 7 to 12 years old with asthma.
Purpose of the Study
The primary purpose of this study was to examine the association between the
amount of inhalation of Albuterol (+ A. Sulfate or Salbutamol) and the use of spacers
among 7 to 12-year-old children with asthma. In this study, I sought to determine if the
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled varied with the use of spacers
when used by children with asthma aged 7 to 12 years old suffering an asthma attack
episode. The variables were Albuterol (+ A. Sulfate or Salbutamol) and the use of
spacers; the population sample was children aged 7 to 12 years with asthma. The
variables were examined to address the research questions and develop new insights into
the current health issue to create useful and practical approaches in designing and
implementing a prevention program, potentially leading to positive social change.
Additionally, the study improved the knowledge of the delivery of asthma medication,
increasing children’s awareness of the proper use and maintenance of inhalers.
Research Questions and Hypotheses
Research Question (RQ)1-Quantitative: What is the association between the
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers
among children 7 to 12 years old?
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H01: There is no significant statistical association between the amount of Albuterol
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to
12 years old.
H1: There is a significant statistical association between the amount of Albuterol
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to
12 years old.
Research Question (RQ)2-Quantitative: What is the association between the
number of asthma episodes or attacks with or without professional inhalation
instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in
children 7 to 12 years old?
H01: There is no association between the number of asthma episodes or attacks
with or without professional inhalation instruction on the proper delivery of
Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old.
H02: There is an association between the number of asthma episodes or attacks
with or without professional inhalation instruction on the proper delivery of
Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old.
Theoretical Foundation for the Study
This study's theoretical framework was the transtheoretical model or stages of
change (see Keshmiri et al., 2017). This theory was appropriate to this study because it
examines an individual’s ability to act on new healthier behavior and provides strategies
or approaches for change to guide the individual in reaching a desired health outcome
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(Keshmiri et al., 2017). According to Keshmiri et al. (2017), participants can be at any of
the six constructs of stages of change:
1. Precontemplation
2. Contemplation
3. Preparation
4. Action
5. Maintenance
6. Termination
The individuals undergo each stage to increase compliance with inhaled
medications. The significance is that the transtheoretical model assists individuals in
adopting a new behavior, whether to use an inhaler with medicines to prevent asthma
episodes or attacks among asthmatic children. The transtheoretical model guides the
children with asthma to learn and comply with the proper use of inhalational techniques
and interventions to achieve their desired health outcomes. The transtheoretical model is
a valuable tool to guide and counsel participants to reach their desired health outcomes
using the interventions published in a health program (Daniels et al., 2014). This
particular framework comprehensively assesses behavior change and the design of
effective interventions (Gold et al., 2016). Berhane, Biadgilign, Berhance, and Memiah
(2015) stated that the six constructs of the model act as the model of behavior change to
articulate how and why people alter their behaviors.
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Nature of the Study
The nature of this study was a cross-sectional research design data analysis that
has been conducted using Statistical Package for the Social Sciences (v.25) Software. The
dependent variable was the number of canisters Albuterol (+ A. Sulfate or Salbutamol).
The independent variable was Albuterol (+ A. Sulfate or Salbutamol) with or without a
spacer. For the second research question, the dependent variable was the duration of
asthma episodes or attacks in children, and the independent variable was with or without
an inhalation technique instruction given by a professional. Using quantitative research
for this study can develop numerical data that provides meaningful new insights that
support generalizations related to the phenomenon under study. The quantitative research
was performed to provide statistical analysis that validated the association between two
or more variables and measured trends or the incidence of various views.
The quantitative research design addresses cause and effect relationships and,
therefore, can be relied on to create predictions. Quantitative research can report credible
statistics results to help answer the research questions. The quantitative research design
establishes statistical numbers and associations between variables that can be described
using figures, graphs, and inferential statistics. Further, my investigation addressed
asthmatic children in that I was interested in understanding asthma episodes or attacks
determined by the amount of medication inhaled with and without a spacer. In this
research study, I focused on investigating the association of the number of canisters of
Albuterol (+ A. Sulfate or Salbutamol) with or without a spacer used in children with
asthma in the age group of 7 to 12 years old. Additionally, I investigated the association
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of the duration of asthma attacks and episodes on children with asthma and whether they
received professional instruction on how to operate an inhalation device correctly.
Literature Search Strategy
The literature review provided an overview of an Albuterol (+ A. Sulfate or
Salbutamol) inhaler with and without a spacer in children ages 7 to 12 years with asthma.
The keywords searched were spacers, inhalers, inhalation technique, medications,
asthma, children, public health, doses, education, quality of life, respiratory disease,
medication adherence, asthma control, asthma symptom control, asthma knowledge,
medication nonadherence, asthma outcome, and pediatric in the databases Google
Scholar, PubMed, and EBSCO. The keywords listed above were tailored to the scope of
the study using the appropriate databases with peer-reviewed scholarly articles reviewed
that were published from 2015 and 2019.
Literature Review Related to Key Variables and/or Concepts
Health Issue: Asthma
Asthma is one of the concerns in public health because it develops adverse health
effects in children. Asthma is a chronic disease, is heterogeneous, and is an inflammatory
disease of the respiratory system (Ibrahim et al., 2019). Coughing, wheezing, chest
tightness at night, and breathing difficulties are indicators of asthma in children (Furtado
et al., 2019). This health issue needs to be addressed to improve and obtain the desired
positive health outcome in the population. According to Gillette et al. (2016), about 7
million in pediatric populations in the United States are affected by asthma.
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Asthma leads to chronic disease in children, and it increases the number of
hospital visits (Ahmad et al., 2018; Jat et al., 2016; Tattersall et al., 2018). Asthmatic
children left untreated are most likely to experience several challenges in their life
mentally and impaired quality of life (Greenlee, Winter, Fiese, & Everhart, 2019). The
impairment to quality of life limits children's daily activities such as in sports and games,
and they may experience difficulties interacting with family members, anxiety, and
disrupt functionality because of the disease (Kocaaslan & Akgun Kostak, 2019).
Understanding the factors associated with the adverse outcomes for children with asthma
is crucial to identifying interventions and preventions to alleviate the condition's
symptoms more effectively.
Quality of Life for Children With Asthma
There are several effective treatments and interventions available to treat asthma;
however, asthma continues to negatively impact children's quality of life when these
treatments and interventions are not always implemented correctly. Quality of life plays a
vital role in monitoring asthma control (Melgarejo González-Conde, Pérez-Fernández,
Ruiz-Esteban, & Valverde-Molina, 2019). Quality of life is used as an indicator for
children who have asthma as the condition negatively impacts their physiological
development, drastically affecting physical, mental, and emotional health (Kocaaslan &
Kostak, 2019). Asthmatic children may experience a lower tolerance for physical activity
and are more likely to stay indoors than other children without asthma (Furtado et al.,
2019). Self-efficacy refers to an individual who can perform behaviors necessary to
manage asthma symptoms and maintain a positive health outcome (Melgarejo González-
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Conde et al., 2019). Children with proper asthma education can provide care for
themselves with minimal supervision. Professionals providing care to children with
asthma need to comply with and understand the national guidelines to effectively
implement an asthma management plan (McCabe, McDonald, & Lipman, 2019).
Children with asthma tend to eliminate their extracurricular activities and be bullied
because of their symptoms (Carey, Edds-McAfee, Martinez, Gutierrez de Blume, and
Thornton, 2019; Kalyva, Eiser, & Papathanasiou, 2016). Poor asthma control affects the
quality of life. For example, children may be discouraged from attending school or
academic performance may be impacted; the parents may also need to miss work to
provide care for their child (Carey et al., 2019; Ellis et al., 2019).
Poor asthma control increases the rate of morbidity, limits daily activities, and
negatively impacts children's overall health status (Quirt, Hildebrand, Mazza, Nova, and
Kim, 2018). Children with asthma are often unable to attend school for at least two
consecutive days more than children without asthma (Carpenter et al., 2016). Individuals
who care for children need to provide continuous guidance to manage their asthma and
support related decision-making. Asthma impacts the quality of life of children in several
ways. Therefore, it is critical for health care providers to form a concept for medical
treatment and education for asthmatic populations to manage children's asthma
symptoms.
Emergency Department Visit
Children with asthma who do not effectively use an inhaler during asthma attacks
or episodes may encounter difficulties controlling asthma and may need to seek
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emergency treatment more frequently. Patients may be required to visit the ED more
frequently due to poor asthma management and control (Storms, Tringale, & Ferro,
2015). Effective interventions help address asthma symptoms; however, there are more
asthma-related ED visits than primary care visits in children with asthma (Celik, Araz,
Bastani, & Saenz, 2017). In the United States, asthmatic children are more likely to visit
the ED and require hospitalization than older adults (Al-Muhsen et al., 2015). Patients
need a higher level of asthma management if they have been hospitalized because of
asthma exacerbations (Basheti, Obeidat, & Reddel, 2018). When a high-risk population
of asthma patients visits the hospital because of asthma episodes or attacks, they will be
educated and provided with self-management skills to control asthma symptoms (Basheti
et al., 2018). Educating the patients at every hospital visit, particularly on inhaler
technique skills, is vital as incorrectly operating an inhaler device leads to more ED visits
in children (Carpenter et al., 2016). Effective asthma education is critical for asthmatic
children because it reduces hospital admissions, improves functionality, and achieves
more positive health status (Grover et al., 2016). In a previous study, Ali et al. (2019)
showed that providing asthma education with patients one at a time is associated with
asthma control, fewer ED visits, and fewer hospital admissions. Administering
prophylactic inhaled corticosteroids has been shown to reduce the severity of the
problem, but without appropriate guidelines on how to use the medication effectively, it
can cause a relapse of symptoms (Ali et al., 2019). It is still unclear whether a lack of
knowledge impacts the delivery of medication and the occurrence of exacerbations and
ED visits. In the previous study, researchers did not have sufficient information about
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whether a child's age can be a factor during inhalation regardless of if a child was
instructed by a healthcare professional (Ali et al., 2019). Several research findings
revealed that not providing credible asthma education to the asthmatic population may
lead to poor asthma control, and symptoms may prolong (Ali et al., 2019). The
insufficient information to explain the association between asthma education and drug
delivery may make it difficult to manage asthma attacks or episodes, and the asthma
patient might continue to develop severe medical complications.
Inhaler Device
An inhaler is the method of medication delivery in the lungs for asthmatic
children. The goals of the inhaler devices are to control asthma symptoms and alleviate
risks. Inhaler devices are the primary route to administer adequate drugs in the airways to
treat asthma (Pessôa et al., 2018). According to Gillette et al. (2016), inhaler devices are
the preferred medication delivery method in asthma straight to the lungs. However, if the
appropriate number of doses is not inhaled, there is a likelihood that a child may
experience asthma episodes or attacks, especially when it is inadequate for breathing
during the inhalation (Zoltan, 2015). The inhaled treatment has many positive impacts on
treating asthma because of the high delivery concentration of the drug straight to the
airways with a few side effects, but demonstrating incorrect technique turns to the
inefficacy of treatment (Türkeli, Yılmaz, & Yüksel, 216). The inhaler devices continue to
affect asthma outcomes, and an inhaler device is becoming an essential choice for asthma
control medication (Gillette et al., 2016). Asthma can be controlled more effectively
when the children use an inhalation technique correctly (Gillette et al., 2016). Inhalers are
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crucial tools to immediately treat asthma exacerbation and control for patients with
persistent asthma (Ali et al., 2019). A child is expected to have the ability to correctly use
the inhaler device as it is known to be an essential factor for successful asthma treatment
(Juntunen-Backman et al., 2015). However, patients continue to misuse an inhaler device
even though they were trained on the correct technique (Aydemir, 2015). Adherence to
the proper procedures may reduce asthma attacks or episodes. Operating the inhalation
techniques properly could also reduce visiting the emergency room. For long-term
treatment, the inhalation devices might be an appropriate tool to use for asthma
management; however, the device's effectiveness depends on how the inhalation
technique is performed (Mebrahtom, Mesfin, Gebreyesus, & Teweldenmedhin, 2019).
Incorrectly using an inhalation technique can substantially reduce treatment effectiveness
(Mebrahtom et al., 2019). Some evidence has indicated that misusing an inhaler can
cause only a small amount of medication to be delivered to the lungs (Mebrahtom et al.,
2019). However, it is not clear if this is also due to the absence of a spacer attached in an
inhaler. Misusing an inhaler device decreases drug delivery, and the patients may
encounter consequences with asthma health complications (Almomani, Mokhemer, AlSawalha, & Momany, 2018). Inadequate drug delivery to the lungs can be the result when
patients do not operate an inhalation device correctly, causing the prevalence rate of
asthma to rise consistently (Kovačević et al., 2018). Patients may still perform the
inhalation techniques poorly, even after instructions (Kilgore, Al Katranji, Woodall,
Shepherd, and Flesher, 2016; Jat et al., 2016). Previous studies have indicated that a lack
of controlling asthma might be in part due to the improper usage of the inhaler devices
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(Kilgore et al., 2016). Nevertheless, previous researchers did not state if using spacers
would improve the drug delivery regardless if the patients incorrectly operated the inhaler
devices or missed a few steps in sequence.
Asthma Education
Researchers have suggested that 67% of health care providers are unable to
demonstrate the correct inhaler technique to their patients (Kilgore et al., 2016; Root &
Small, 2019). An inhalation device is a standard route to administer asthma drugs, but
few health care professionals have the competence to teach the technique to their patients
(Velasco et al., 2015). When a pharmacist provides education regarding the proper use of
an inhaler in children, it improves the symptoms and inhaler technique and decreases the
number of ED visits and hospitalizations (Zarmouh, 2019). When health care
professionals deliver the instructions to patients, the adherence and inhaler technique
improve in children, but the ED visits, hospitalizations, and symptoms remain the
concern (Zarmouh, 2019). This indicates that a patient’s use of an inhalation technique
depends on how it was taught, and, therefore, poorly controlling asthma is not solely
because of how it was performed or the absence of a spacer with an inhaler. The practical
education or instruction on how to operate an inhaler seems to depend on who provides
the materials. It is unclear whether the pharmacists or other healthcare professionals
should disseminate information on effectively performing the inhalation technique to
better control asthma in children. Although a correct inhaler technique seems
understandable and easy to follow, many patients tend to forget the inhaler vocal training
they have received (Al Ammari et al., 2017).
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The factors to unsuccessfully control asthma are a lack of education about the
correct inhaler technique, and the learning process is complex to adhere to several
asthmatic children (Ali et al., 2019). The lack of knowledge about asthma, inadequate
inhaler training, and low level of health literacy impacts a patient’s ability to operate an
inhaler accurately (Axtell, Haines, & Fairclough, 2017). Many inhaler devices users may
experience discouragement because of a lack of benefit from treatment (Jat et al., 2016).
The patients or parents might have received training about the correct use of
inhalers by a professional. However, if these audiences do not understand the information
provided, it may be a factor to incorrectly operating an inhaler with or without a spacer.
The patients or parents of patients who do not understand the health information provided
for the proper use of the medication may improperly administer the drug resulting in the
worsening of asthma symptoms severity and increase the rate of hospitalizations (Yin et
al., 2019). Health care providers often identify the appropriate inhaler device for their
patients and are knowledgeable enough to teach their patients the correct inhaler
technique; however, they may overlook assessing the level of proficiency (Kshatriya,
Khara, Paliwal, & Patel, 2016). In the event of an asthma attack or episode, the first
selection of the method to treat it is the metered-dose inhaler (Ozkars & Kirik, 2019).
There are some cases that it may prove difficult to learn the proper technique of
medication use (Ozkars & Kirik, 2019). The medication will not reach the airways and
may prove ineffectual if children do not use the inhaler incorrectly (Ozkars & Kirik,
2019). Aside from using an inhaler correctly, a tool called the “spacer” attached to an
inhaler could prevent the medication from escaping and more of the medicine deposited
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in the lungs. When children encounter difficulties in using inhaler devices, the result may
decrease adherence, resulting in ineffective drug delivery. The researchers in the previous
study discussed several effective inhalers to use to treat asthma with the proper inhalation
technique instructions to treat asthma. However, it is unclear whether this method has
reduced the symptoms and prevalence of asthma in the children population, specifically
ages seven to 12 years old.
Spacers
Using spacers with an inhaler may be beneficial to improving drug delivery in the
lungs. The spacers might have the features that allow most of the medications to be
inhaled through the lungs by requiring the patient to coordinate the actuation and
breathing sequence. A spacer attached to an inhaler device may increase the deposition of
drugs in the lungs if the patients provide adequate coordination of inspiration (Guilbert et
al., 2017). The inspiratory flow rates are a critical factor in inhaling the appropriate
amount of drug delivery (Haidi et al., 2016). Failure to perform hand-breath coordination
can fail to deliver an adequate amount of medication into the lung with in-breath (Sanders
& Bruin, 2015). Young asthmatic children should utilize an inhaler with a spacer to
prevent insufficient coordination compared to older asthmatic children should use a dry
powder inhaler device with a proper breathing sequence (Pinto, Jeri, & Barbosa, 2018).
Insufficient hand-breath coordination or inspiratory flow rate may influence during the
inhalation procedures, and fewer drugs deliver through the lungs (Vandewalker, Hickey,
& Small, 2017). Schoessler and Winders (2016) also stated that a spacer does not suspend
the medication in the air, but it holds the drug in the chamber. Schor et al. (2017) further
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stated that spacers could reduce the requirement for hand-breath coordination and
enhance lower airways by improving the efficacy of dose inhalers in delivering
medications.
An inhaler without a spacer provides a smaller number dose of the treatment to
the airway; some medications stay on the tongue, and the rest may be wasted into the air
(Babaei, Najafi, Khosh Boo, & Ghesmati, 2018). Using a spacer with an inhaler prevents
drugs from escaping in the air and improves drug penetration into peripheral airways
(Schor et al., 2017). Some studies have shown that using spacers with different inhalers
such as pressurized metered-dose inhalers (pMDIs) may result from increasing the total
amount of drug available for inhalation (Guilbert et al., 2017).
Childhood asthma is most likely to occur in the preschool years, and for this age
group, the MDI treatment will principally be to administer with a spacer (Topal et al.,
2018). The previous study has shown that MDI treatment with a spacer will be the
appropriate treatment for asthmatic children. However, it is unclear whether the particular
children’s population received formal instruction or help from their parents during the
inhalation and whether asthma episodes or attacks have occurred after the treatment. A
health care provider might need to reinforce asthmatic children to use spacers with an
inhaler to administer medications regardless of the type of drugs being inhaled. Kilgore et
al. (2016) added that using a spacer is beneficial because it increases the likelihood of
health improvement and reduces symptoms. Asthma treatments should be administered
throughout periods of well-being to avoid attacks or episodes in children (Aslam, Shakir,
& Murray, 2016). The desired health outcome is not feasible to achieve if the children
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continue to administer medication incorrectly. Children that failed to comply with the
asthma management plan resulted in poor asthma control and risk developing severe
chronic health conditions.
Children not using a spacer on an inhaler significantly decrease the effectiveness
of aerosol therapy of children, increasing the risk of complications (Newhouse & Amirav,
2019). Several factors lead to poor asthma control, including a poor understanding of
multiple inhalers use, a lack of spacer availability, and social stigmatization (Ammari et
al., 2017). Based on the previous studies, the medications administered by a health care
professional indicated some improvement in controlling asthma and reduced ED visits as
well as hospitalizations (Ellis et al., 2019). There are several critical steps to follow when
delivering asthma drugs using an inhaler that cannot be missed because it impacts the
number of medications inhaled into the lungs, and asthma symptoms may be challenging
to treat as a result. When the misuse of an inhaler occurs, it may significantly increase the
incidence and prevalence rate of asthma in children. Misusing an inhaler might also lead
to the severity of the health problem. The researchers did not provide sufficient
information about medication delivery, whether the amount of an inhaler with the
appropriate medical care can obtain asthma control. There are several inhalers to
administer medications to treat asthma and have been accepted widely. Unfortunately, the
researchers on the previous studies do not further discuss the rationale as to why children
continue to control asthma very poorly and develop symptoms even if this population
received the appropriate professional instructions on how to deliver drugs using an
inhaler, whether using a spacer.
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The researchers did not investigate whether using a spacer with an inhaler would
improve the delivery of Albuterol (+ A. Sulfate or Salbutamol) to the lungs and
improving control of asthma symptoms in all children. Although a spacer prevents the
treatment from evaporating, it is unclear whether the rate of inspiratory influences the
drug delivery in the lungs; without new approaches or directions to address the health
problem, asthma may develop severe health complications in children and remains an
important concern in the field of public health.
Definitions
The amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled whether using an
inhaler is the dependent variable, and age and asthmatic children are the independent
variables for the first research question. The asthma severity is the dependent variable,
and inhalation technique instruction during asthma episode or attack, age, and asthmatic
children are the independent variables for the second research question.
Albuterol (+ A. Sulfate or Salbutamol): A medication to treat asthma. Albuterol
(+ A. Sulfate or Salbutamol) is a glucocorticoid used to treat allergies, inflammation, and
prevent worsening of asthma through inhaled or injection (Reggie, Neimkin, & Holds,
2018).
Asthma control: Published guidance provided by a physician for patients to
adhere to asthma attacks or episodes occurs. The use of asthma treatment reduces the
symptoms and lessens the duration of an asthma attack or episodes (Akiki et al., 2019).
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Asthma knowledge: Patients received asthma education provided by a professional
about the steps need to execute in case of asthma attacks. According to Luckie et al.
(2018), asthma education is a verbal or written instruction by a medical practitioner.
Asthma symptom control: Inhaling medications to control asthma symptoms and
treat airway inflammation. A respiratory disease increasing the risk of developing
asthma, or the asthmatic condition becomes progressively worse (Grosso et al., 2019).
Asthmatic children: A population of children (seven-12) years old with asthma. A
group of asthmatic children may represent an allergic airway inflammation (Licari,
Fuchs, Marseglia, & Ciprandi, 2019).
Chronic obstructive pulmonary disease (COPD): A lung disease that prevents
airflow and causes shortness of breath. COPD is an inflammation, persistent airflow
limitation, and mucous obstruction (Atanasova & Reznikov, 2018).
Current asthma: An individual diagnosed with asthma by a primary care
physician and shows symptoms such as wheezing, nocturnal chest tightness, attack of
shortness of breath, or medication use for breathing problems (Akiki et al., 2019).
Healthcare professional: Multidisciplinary team involved in direct patient care of
asthmatic children. Healthcare professionals include nurses, primary care physicians,
respiratory therapists, pharmacists, pediatricians, pharmacy technicians, and other clinic
personnel licensed to provide care and treatment to asthmatic patients (Plaza et al., 2018).
Inhalation technique: A tool that is designed to deliver asthma medications in the
human body. Sufficient amounts of drugs are distributed in the lungs when performing an
inhalation technique correctly (Gregoriano et al., 2018).
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Inhaler: Is a controller medication, which is the mainstay of the management of
persistent asthma (Ferro et al., 2019).
Instructional mode (education): A published instruction provided by a health
provider that guides the usage of an inhaler when administering medications.
Instructional materials guide asthmatic patients to manage asthma and enhance learning
performance (Moussa-Inaty, Atallah, & Causapin, 2019
Spacers: A tube that attaches to the inhaler and holds medication that assists get
the medications into the lungs. A spacer is a tool attached to an inhaler to prevent drugs
from escaping in the air to deliver adequate drugs (Ming et al., 2019).
Quality of life: Changes the health status of children negatively due to asthma
symptoms, attacks, or episodes. Asthma symptoms can lead to an asthma attack that
impairs the population's quality of life (Crossman-Barnes, Sach, Wilson, & Barton,
2019).
Assumptions
The participants provided appropriate and sufficient information in response to
the survey questionnaires of the secondary data. Thus, the inclusion criteria are relevant
and assure that the participants have all encountered the symmetrical phenomenon of the
study. These assumptions were necessary for the context of the study because it is
imperative to develop meaningful results that answer the research questions leading to
developing the appropriate recommendation for future research of the phenomenon and
social change.
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Scope and Delimitations
Scope of the Study
Asthma remains to be the primary concern in public health that disrupts the health
of children. An insufficient amount of medication delivered into the lungs due to
improper usage of an inhaler with or without spacers results in difficulties controlling
asthma outcomes. Therefore, the prevalence and incidence rate of asthma in children is
continuously stationary. Focusing on these aspects to provide solutions and identify
effective interventions to a health issue is imperative. Following an intervention
effectively mitigates the factors that cause a long period of asthma attacks or episodes,
and the children may achieve their desired positive health outcome as a result.
Delimitations
The study consisted of asthmatic children, ages seven to 12 years old. It included
children who have been administered with various asthma medications such as Albuterol
(+ A. Sulfate or Salbutamol) with an inhaler technique, whether using spacers. The study
excluded older adults as well as children ages 1 to 6 and thirteen and up. The population
that does not have a history of an asthma attack was excluded from the investigation.
Significance
The results of this study provided new insights and filled in the gaps in the
literature that address the problem and health issue of children with asthma. This study
also addressed the gaps by articulating the effect of inhalation of Albuterol (+ A. Sulfate
or Salbutamol) using with or without spacers in children with asthma to improve the
outcome of asthma and quality of life for children. Further, the findings may contribute to
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the evidence-based practice to reevaluate and modify the health policy to ensure that
decisions, plans, and actions that occur achieve the goals in health care within a society.
My research findings provided essential insights, thus, identifying the practical
approaches to help alleviate the risk factors and prevent the development of the health
issue. The results may trigger an increased awareness of the health issue in public health
that will change individuals’ behavior leading to developing effective decisions to
achieve their desired health outcome. The results allow creating an intervention that will
reduce the new incidence rate of the health issue and reduce the burden about the health
issue in the field of public health. The comprehensive new insights from this study will
benefit social change, such as maintaining and promoting a positive health outcome in the
children population.
Summary
Asthma is a chronic disease that constricts the lungs' airways and develops health
complications such as shortness of breath, chest tightness, and coughing. Asthma remains
the health issue in the field of public health that practitioners need to mitigate. There are a
considerable amount of studies pertaining to asthmatic children. The previous studies
have provided a piece of in-depth information on the risk factors, causes, symptoms,
prevention, and asthma medications. However, there is insufficient evidence as to what, if
there is a relationship between the amount of Albuterol (+ A. Sulfate or Salbutamol)
whether using a spacer delivered in the lungs. At the same time, a healthcare provider
provides users with proper instructions. Using an inhaler with or without a spacer,
improperly affects the amount of asthma medication delivered in the lungs. Therefore,
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asthmatic children will not be treated medically and encounter difficulties in obtaining
the desired health outcome. This study focused on investigating the association of
Albuterol (+ A. Sulfate or Salbutamol) with or without a spacer in children with asthma.
Also, it investigated if the severity of asthma among children depends on the improper
usage of the inhalation technique during administering medications. It was imperative to
conduct this study to fill the literature gaps and develop a new conceptual framework to
address asthma in the population. The findings of the study promote social change in the
population and enhance the knowledge of healthcare providers leading to improving the
medication delivery method to improve health and reduce the new incidence rate of the
children.
Conclusion
Asthma, regardless of cause, is an often-chronic disease, and one that remains a
significant concern to public health. Asthma is associated with adverse effects on
children's health, and it is critical to investigate and identify solutions that reduce these
adverse health effects. It remains imperative to investigate the complexity of these
associated problems to determine effective solutions. Doing so will improve children's
health and reduce the severity of the development of asthma in the population. The result
of the study added information in the literature and provided additional knowledge on
how to manage or control asthmatic children. The findings of this study have shown
effective strategies exist for the target population, and health care providers and
adherence to these strategies are critical in reducing the effects of asthma attacks, by
extension, reducing the frequency of visits to ED. The results of this study provided new
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insights that have promoted positive social change, providing a more in-depth
understanding of asthma that children, parents, and health professionals can add to best
practices in maintaining positive health status.
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Section 2: Research Design and Data Collection
Introduction
The purpose of this study was to investigate the association of an Albuterol (+ A.
Sulfate or Salbutamol) inhaler with and without spacers in children with asthma. In
Section 1, I discussed the various effects of asthma in the target population and
worldwide. This study was important to identify if the amount of medication delivered in
the lungs with or without a spacer precipitates an asthma attack or episode. Through this
research, I explored if the severity of asthma in children has a relationship with the
instructions provided by a professional when administering drugs using an inhaler device.
Overall, the results of this study can be used to develop innovative approaches to improve
the delivery of medication and how to effectively use an inhaler, whether used with or
without a spacer.
Research Design and Rationale
For the first research question, the dependent variable was the number of canisters
of Albuterol (+ A. Sulfate or Salbutamol). The independent variable was Albuterol (+ A.
Sulfate or Salbutamol) with or without a spacer. For the second research question, the
dependent variable was the duration of asthma episodes or attacks in children, and the
independent variable was with or without an inhalation technique instruction given by a
professional.
In this quantitative research study, I used a cross-sectional design. The research
design allowed me to further investigate the association of the amount of medication
delivery with or without a spacer in the children population. I also identified the
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association between the duration of asthma episodes or attacks and children with and
without an inhalation instruction provided by a health care professional in the age group 7
to 12.
Methodology
Population
This study involved asthmatic children ages 7 to 12 years old. The Behavioral
Risk Factor Surveillance System (BRFSS) Asthma Call-Back Survey (ACBS) collected
data in all 50 states, including the District of Columbia and the U.S. territories (Centers
for Disease Control and Prevention [CDC], 2015). In the 2015 child landline-cell phone
combined data file, there were 1,146 records from nine states and Puerto Rico.
Sampling and Sampling Procedures
The BRFSS performed data collection in each state in the United States using a
telephone survey system tailored to the individual’s health risk factors, chronic diseases,
and available preventative services (CDC, 2015). The BRFSS is partnered with the CDC
to receive assistance in technical and methodological aspects by having interviewers and
contractors with telephone call centers or universities in the state health department to
conduct the BRFSS surveys throughout the year (CDC, 2015).
As far as the BRFSS ACBS questionnaire components, each state in the United
States was mandated to use the published standard core questionnaires, modules, and
stated questions. Random digit dialing techniques on both landlines and cell phones
execute surveys during the data collection (CDC, 2015). The questionnaires in the
surveys and any modifications to the questionnaires needed approval from the BRFSS
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state coordinators and the CDC before it could be published. A proposal needed to be
submitted if the BRFSS desired to add new questions in the questionnaires (CDC, 2015).
Each state coordinator who submits a proposal requires presenting a rationale that
supports the questions. The CDC (2015) requires each state coordinator to provide an
explanation that supports the questions in the proposal, which are the (a) original
question, (b) history of prior cognitive, (c) validity testing, (d) history of prior use, and
(e) analytical plan. Most importantly, the proposed questions need to comply with the
primary and secondary criteria related to a Healthy People 2020 objective or concern
health issue and the needs of the stated department (CDC, 2015). There are different
stages that the BRFSS states coordinators will undergo before approving the new
questions in the questionnaires, which are (a) a technical review, (b) cognitive testing,
and (c) field testing (CDC, 2015).
The BRFSS used poststratification as the statistical weighting method because the
number of interviews within each state might differ according to the funding and size of
regions – health districts. The age, sex, ethnicity, states, marital status, education level,
homeownership, and type of phone ownership were the variables used to weight BRFSS
data.
The data produced by federal agencies are accessible in public and may be
reproduced without prior permission. However, it is necessary to ensure and critical to
acknowledge that the CDC’s BRFSS is the original source for the materials or data
published in public. The Annual Survey Data section, comprehensive materials, data
files, codebooks, design documents, and methodology are on the BRFSS’s website.
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Data Collection
Data collection for the ACBS included the use of both landline and cellphone
(LLCP) samples, which were the required protocols in each state. Each state possesses a
BRFSS interview schedule and expects to administer all calls for a given survey month
within a similar sample month. It is possible to make up to 15 calling attempts for each
phone number in the sample; however, state regulations must adhere to calling. The
BRFSS (2019) protocols claimed that the five calling occasions to consider when
conducting surveys are (a) to perform 20% of the interviews on weekdays, (b) to hold
80% on weeknights and weekends, (c) to note that schedules may be modified in
observance to holidays and special events, (d) to make weekday calls just after the dinner
hour, and (e) to make appointment call-backs during hours that are not scheduled for
other interviews. ACBS collected data for the child from 26 states/territories. The child
LLCP, who met data quality standards from the states/territories that performed both
LLCP samples from 10 states/territories for the child data are available in public. The
ACBS questionnaires were published in English and are available in Spanish. An adult
aged 18 must be present to take a survey and is a proxy to the child.
Inclusion Criteria
The states that participated in the child LLCP ACBS in the year of 2015 and are
included in the data and released in public are Connecticut, Kansas, Michigan,
Minnesota, New Jersey, Ohio, Utah, and Puerto Rico.
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Exclusion Criteria
The data that were gathered through LLCP samples from California, Georgia,
Hawaii, Indiana, Maine, Massachusetts, Mississippi, Missouri, Montana, New
Hampshire, New Mexico, New York, Oklahoma, Oregon, Pennsylvania, Rhode Island,
Vermont, and Wisconsin were excluded because these states accumulated less than 75
records and thus were ineligible to produce reliable weights. Also, Florida, Illinois, Iowa,
and Nevada did not collect child ACBS data. Florida did not collect cellphone data in
January, February, March, and April 2015. The among weighted states with no record of
ACBS participation in the LLCP data for children, including Minnesota, Nebraska, New
Jersey, Texas, Utah, more than 10% were not included in the data. The modified
adjustment factor method was used for these states for weighting purposes.
Power Analysis
To identify the required sample size for my study, I used the G*Power3 software.
The G*Power3 software is used to determine the appropriate sample size for statistical
analyses (Gignac & Szodorai, 2016). Using the G*Power3 analysis, the sample t tests,
with effect size 0.5, alpha level 0.05, and power 0.95, a sample size of 176 was
necessary. The power analysis occurs in the research process as well as during data
analyses (Pek & Park, 2019). The power analyses are responsible for identifying the
smallest sample size that is appropriate to detect the effect of the test statistics (Pek &
Park, 2019). The study results relied on statistical power, and having a low sample size
may cause a higher number of false negatives, false positives, or inability to show
association (see Gjerdevik et al., 2019). Incorporating the Power*G3 software to identify
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the sample size in my research study was an essential component in the data analysis in
order to answer the research questions.
Instrumentation and Operationalization of Constructs
The secondary data were accessed from the CDC – ACBS that was conducted
from 2006 to 2015 as part of the BRFSS. The BRFSS-ACBS data published in 2015 were
used as the secondary data, which were accessed in the public database. However,
permission to use the data was submitted to the CDC before accessing the codebook. The
ACBS used the appropriate instruments for the current study as it collected information
about chronic diseases, medications, socioeconomic status, behavioral, and
environmental predictors that relate to better control of asthma.
Operationalization
There were two dependent variables in this research study: the amount of
Albuterol (+ A. Sulfate or Salbutamol) inhaled and asthma duration (Table 1). There
were three independent variables: age-group, Albuterol (+ A. Sulfate or Salbutamol) with
or without a spacer, and professional inhalation instruction (Table 2). The independent
variables were analyzed to identify the association with the dependent variables.
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Table 1
Dependent Variables
Variables

Measurement

Survey question

Data values or
units
____canisters,
don’t know,
none, refused

Number of canisters
Albuterol (+ A.
Sulfate or
Salbutamol)

Ratio

How many canisters of
[medication’s name] has
[child’s name] used in the
past 3 months?

Asthma duration

Ratio

During the past three
months, how many asthma
episodes or attacks has
[he/she] had?

None, don’t
know, refused

Variables

Measurement

Survey question

Data values or
units

Age-group

Ordinal

Child asthma call-back age
group questionnaire

Age 0-6, age 712, age 13-17

Albuterol (+ A.
Sulfate or
Salbutamol) with or
without a spacer

Nominal

Does [he/she] use a spacer
with [medication’s name]?

Yes, no

Professional inhaler
instruction

Nominal

Did a health professional
show [him/her] how to use
the inhaler?

Yes, no, never
took asthma
medication,
never used

Table 2
Independent Variables
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Data Analysis Plan
Statistical Package for Social Sciences (v 25) by IBM was used to perform data
analyses for the asthma call-back survey 2015 data. Before performing data analyses, it is
necessary to execute data cleaning and implementing screening procedures by examining
the data thoroughly for entry error, to ensure that the data correctly reflects the responses
provided by the participants, identify missing data and ensure that the variables needed to
answer the research questions are included in the data. Since this was quantitative
research, cleaning the data entailed identifying missing data from the data entry, which
can be detected from the frequencies of the variable. During the data screening, it was
vital to identify a pattern to the missing data, if any, double entries, outliers, and
unreported results. Missing values were detected in the data, and therefore, a
transformation feature was utilized to address them; likewise, the sample was sufficient
for my study.
The data analysis was intended to answer the following research questions below
and accept or reject hypotheses:
Research Question (RQ)1-Quantitative: What is the association between the
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers
among children 7 to 12 years old?
H01: There is no significant statistical association between the amount of Albuterol
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to
12 years old.
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H1: There is a significant statistical association between the amount of Albuterol
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to
12 years old.
Research Question (RQ)2-Quantitative: What is the association between the
number of asthma episodes or attacks with or without professional inhalation
instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in
children 7 to 12 years old?
H01: There is no association between the number of asthma episodes or attacks
with or without professional inhalation instruction on the proper delivery of
Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old.
H02: There is an association between the number of asthma episodes or attacks
with or without professional inhalation instruction on the proper delivery of
Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old.
Statistical Analysis
The statistical analysis was quantitative research involved descriptive statistics
that demonstrated the frequency counts, ranges (high and low values), means, modes,
median, and standard deviation. This particular test provided a summation of the sample
and measures (Ho & Yu, 2015). The quantitative data are typically demonstrated as
frequency distribution or relative frequency rather than percentage; the upper and lower
limits will depend upon the size of the data (Kulkarni, 2016).
The first research question consisted of a dependent variable, the amount of
Albuterol (+ A. Sulfate or Salbutamol) inhaled. The independent variable was with or

35
without a spacer. The second research question included a dependent variable, the
number of asthma episodes or attacks. The independent variables included with or
without a professional inhalation instruction on proper delivery of Albuterol (+ A. Sulfate
or Salbutamol) and age-group (7-12). A sample t test was used to test the hypotheses and
identify the association of the two variables. A sample t test was appropriate as it
compared two groups and performed a comparison of characteristics of two variable
groups (Plonsky, 2015). The sample size for the experimental and control groups is
essential when using t tests in a study (Kim & Park, 2019). Using this particular test was
imperative to identify the association by comparing the dependent and independent
variables.
Threats to Validity
The BRFSS-ACBS within the CDC collects data for samples by administering the
survey in the population as well as intending to be generalizable. Westreich, Edwards,
Lesko, Cole, & Stuart (2018) stated that an external validity revolves around the
generalizability of findings beyond the experimental context. External validity may arise
as a problem if a study sample is not tailored to the target population or cannot assume
the actual association in a study sample will be the exact effect in the population
(Westreich et al., 2018). The confounding factors, nonexchangeability for
generalizability, and nonrepresentative of a target population are the potential threats to
this particular validity (Westreich et al., 2018). Confounding or covariate factors are the
potential threats to external validity in my research study, including gender, proficiency
level, and ethnicity of the child.
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Internal validity determines whether causation can be inferred from the statistical
conclusions (Richardson, Dalton, Shafer, and Patterson, 2016). This form of validity can
be threatened by those similar threats to statistical conclusion validity and other
assessment factors, including altering the instrument over time or test exposure
(Richardson et al., 2016). Confounding factors and selection biases can threaten internal
validity (Westreich et al., 2018). The study employs a cross-sectional design, which does
not apply to internal validity because the causal relationships cannot be certainly proven.
Statistical conclusion validity determines the accuracy of inference about the
presence and strength of the relationship between two variables (Richardson et al., 2016).
Additionally, it can be threatened by measurement limits (e.g., restricted range),
measurement error (e.g., unreliability), incorrectly applied statistics, unreliable treatment
implementation, and other sources of variance introduced into the experimental setting as
well as by low statistical power (Richardson et al., 2016). These threats can increase the
chance of Type 1 or Type II error or the additional error called Type III error by some
concluding significance or non-significance when in fact, the assessments or the
treatments were not correctly implemented (Richardson et al., 2016).
Ethical Procedures
The ethical concern with the BRFSS with ACBS data was that the Institutional
Review Board (IRB) required that asthma should be discussed with the participants
during an interview process in some states, and other states do not require asthma to be
disclosed. The interviewers must be attentive with the consent informed or a code number
on file before a survey can be administered. A code one (1) is indicated on the file, in
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which the state does require action to link the responses from the two interviews.
Otherwise, ACBS cannot be performed, and there will be no record on file if consent was
denied.
Permission request was submitted to the CDC to utilize the ACBS data conducted
in 2015 within the BRFSS. The CDC provided instructions on obtaining a public data file
tailored to asthma data in children. The Walden University Institutional Review Board
(IRB number: 07-16-20-0741112) has approved my doctoral study to use the ACBS data
conducted in 2015 in the CDC to perform data analyses. My research data and the ACBS
data focused on the children’s population. According to Joshua, Zwi, Moran, & White
(2015), vulnerable children group experience several obstacles to health care, which
include sub-optimal access compounded by social disadvantage and culture or linguistic
barriers, were not aware of care services are being offered, and capacity to use them,
insufficient awareness by health providers of their complex health needs. However, an
18-year or older adult is required to take the questionnaires of the survey for the child.
Therefore, it does not fall onto the vulnerable children group.
Summary
In section 2, I discussed the cross-sectional research design in the study to
investigate further the statistically significant association between the variables at the
0.05 significance level. This study tailored to asthmatic children ages 7 to 12, and data
was extracted from the BRFSS – ACBS within the CDC published in 2015. The survey
dataset was analyzed using SPSS (v.25) and performed descriptive analysis, frequencies,
and sample t tests.
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Section 3: Presentation of the Results and Findings
Introduction
The primary purpose of the research study was to thoroughly investigate the
association between the amount of inhalation of Albuterol (+ A. Sulfate or Salbutamol)
and the use of spacers among 7 to 12-year-old children with asthma. In Section 3, I
provide the results of the statistical analyses and the presentation of findings in tables and
figures. Additionally, I demonstrate the different components of the data collection for
the BRFSS ACBS dataset that was conducted in 2015. This section involves the answers
to the research questions as follows:
Research Question (RQ)1-Quantitative: What is the association between the
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers
among children 7 to 12 years old?
H01: There is no significant statistical association between the amount of Albuterol
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to
12 years old.
H1: There is a significant statistical association between the amount of Albuterol
(+ A. Sulfate or Salbutamol) inhaled with or without spacers among children 7 to
12 years old.
Research Question (RQ)2-Quantitative: What is the association between the
number of asthma episodes or attacks with or without professional inhalation
instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in
children 7 to 12 years old?
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H01: There is no association between the number of asthma episodes or attacks
with or without professional inhalation instruction on the proper delivery of
Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old.
H02: There is an association between the number of asthma episodes or attacks
with or without professional inhalation instruction on the proper delivery of
Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old.
Data Collection of Secondary Data Set
Data collection for the ACBS and the use of both LLCP samples were the
required protocols in each state. ACBS collected data for children from 26
states/territories. The child LLCP who met data quality standards from the
states/territories using both LLCP samples from 10 states/territories for the child data
were available in public. The ACBS questionnaires were published in English and were
available in Spanish. An adult aged 18 or above had to be present to take a survey and
was a proxy to the child.
Timeframe for Data Collection
The ACBS undergoes a pilot study each year, which is a comprehensive asthma
survey administered in 50 states, the District of Columbia, and participating territories
with BRFSS using both landlines and cellphones. The BRFSS has discovered a new
approach to identify respondents with asthma to expand interviewing on a call-back
basis. Thus, it included a larger sample size in each area. States typically follow a
suggested BRFSS interviewing schedule and complete all calls for a given survey month
within a similar sample month. There are up to 15 calling attempts that may be made for
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each phone number in the sample, but it depends on state regulations for calling and
outcomes of previous calling attempts. The data are available within 6 months from the
end of the calendar year of data collection.
Response Rate
The BRFSS respondents who reported ever being diagnosed with asthma were
eligible for the asthma call-back. The weighting methodology for the BRFSS was
changed significantly, and cell phone samples were added to the traditional landline
phone samples. The number of states or territories that respond in the ACBS has
increased each year. However, ACBS follows a rule of not reporting or interpreting point
estimates based on fewer than 50 unweighted respondents.
Demographic Characteristics of the Sample
Tables 3, 4, and 5 display the demographic information of the sample in the study.
The study involved N = 416 participants aged 7 to 12 years with a diagnosis of asthma.
Boys (n = 243) represented 58.4% and girls (n = 172) represented 41.3%. These
individuals lived in Connecticut (10.3%), Kansas (15.4%), Michigan (9.1%), Minnesota
(11.3%), Nebraska (9.4%), New Jersey (13.5%), Ohio (4.6%), Texas (7.5%), Utah
(11.1%), and Puerto Rico (7.9%). As part of the screening process, these children's
parents were interviewed to determine if their child would be eligible for the study.
Because this is a vulnerable population, an 18-year-old or older must be present at the
interview time for completion. This study involved children 7 to 12 years old who were
diagnosed with asthma.
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Table 3
State of Child
Frequency Percent Valid percent Cumulative percent
State
Connecticut
43
10.3
10.3
10.3
Kansas
64
15.4
15.4
25.7
Michigan
38
9.1
9.1
34.9
Minnesota
47
11.3
11.3
46.2
Nebraska
39
9.4
9.4
55.5
New Jersey
56
13.5
13.5
69.0
Ohio
19
4.6
4.6
73.6
Texas
31
7.5
7.5
81.0
Utah
46
11.1
11.1
92.1
Puerto Rico
33
7.9
7.9
100.0
Total
416 100.0
100.0
Table 4
Child Age Age-Group Call-Back
Frequency Percent Valid percent Cumulative percent
Age
Age 7 - 12
416 100.0
100.0
100.0
Table 5
Gender of Child
Gender Frequency Percent Valid percent Cumulative percent
Boy
243
58.4
58.4
58.4
Girl
172
41.3
41.3
99.8
Refused
1
.2
.2
100.0
Total
416 100.0
100.0
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Results of the Study
The chi-square test was applied to test the association between two variables. If
the chi-square test rejects the null hypothesis, then there is an association between the
two variables, which means that there is a statistical association between the two
variables (Zhu & Fang, 2016). Testing for association between two variables is routinely
performed in statistical applications, and Pearson’s Ch-Sq statistic is widely applied to
the test if both variables of interest are ordinal or continuous to measure the association
(Shih & Fay, 2017). I used Cramer’s V test to evaluate and measure the strength of the
association between the amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or
without spacers among children for the first research question as well as the association
between the number of asthma episodes or attacks and with or without a professional
inhalation instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in
children ages 7 to 12. Cramer’s V test and Phi solely confirmed an association between
the two variables, the direction of an association, the strength of an association, and the
statistical significance of the association between the independent and dependent
variables found in this study. Amran, Zaaba, Singh, and Marashih (2017) stated that the
independent variable could be classified as the variable that cannot be changed for the
result. In contrast, the dependent variable can be classified as the variable that can be
changed for the result.
Statistical Assumptions
The chi-square assumptions, including the data in the cells, have frequencies or
counts of cases rather than percentages or some other transformation of the data. The
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levels of the variables are mutually exclusive, and thus, a particular subject fits into one
and only one level of each of the variables. There are two variables both measured at the
nominal and ordinal levels.
Research Question (RQ)1-Quantitative: What is the association between the
amount of Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers
among children 7 to 12 years old?
The expected count is what I would expect to observe if there was no association.
In table 6 and figure 1, I would expect 20 participants have used a spacer, 11 participants
did not use a spacer, and 0.4 participants indicated that medication has a built-in spacer or
does not need a spacer with zero number of canisters inhaled. I would expect 49
participants have used a spacer, 37 did not use a spacer, and one has indicated that
medication has a built-in spacer or does not need a spacer with one number of canisters
inhaled. I would expect 11 children have used a spacer, 32 did not use a spacer, and one
has stated that medication has a built-in spacer or does not need a spacer with the amount
of two canisters inhaled. I would expect ten children used a spacer, six did not use a
spacer, and 0.2 indicated that medication has a built-in spacer or does not need a spacer
with the amount of three canisters inhaled. I would expect 0.6 children used a spacer, 0.4
did not use a spacer, and zero of the participants indicated that medication has a built-in
spacer or does not need a spacer with the amount of 4 canisters inhaled I would expect
0.6 children used a spacer, 0.4 did not use a spacer, and zero of the participants indicated
that medication has a built-in spacer or does not need a spacer with the amount of five
canisters inhaled. I would expect 0.6 children used a spacer, 0.4 did not use a spacer, and
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zero of the participants indicated that medication has a built-in spacer or does not need a
spacer with the amount of eight. I would expect two children used a spacer, one child did
not use a spacer, and zero of the participants indicated that medication has a built-in
spacer or does not need a spacer with the amount of 12 canisters inhaled canisters
inhaled.
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Table 6
Albuterol (+ A. Sulfate or Salbutamol) Medication With or Without a Spacer

Albuterol (+ A. sulfate or salbutamol: if spacer used
Medication has a built-in spacer/does not

Albuterol (+ A. sulfate or salbutamol):

0

Number of canisters

Count
Expected

Yes

No

need a spacer

Total

23

11

0

34

20.4 13.2

.4

34.0

37

2

82

49.1 31.9

1.0

82.0

Count
1

Count
Expected

43

Count
2

Count

12

7

0

19

11.4

7.4

.2

19.0

Count

11

5

0

16

Expected

9.6

6.2

.2

16.0

Count

1

0

0

1

Expected

.6

.4

.0

1.0

Count

1

0

0

1

Expected

.6

.4

.0

1.0

Count

0

1

0

1

Expected

.6

.4

.0

1.0

3

0

0

3

1.8

1.2

.0

3.0

94

61

2

157

Expected
Count
3

Count
4

Count
5

Count
8

Count
12 Count
Expected
Count
Total

Count
Expected
Count

94.0 61.0

2.0 157.0
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Figure 1 shows the number of canisters inhaled whether a spacer is used among children
aged 7 to 12 years.

Figure 1. The number of canisters inhaled whether a spacer is used among children aged
7 to 12 years.
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In table 7, the chi-square test, X2 = 9.479, p = .799. The statistical test tells us that
there is no significant statistical association between the amount of the Albuterol (+ A.
Sulfate or Salbutamol) inhaled with or without spacers among children ages seven to 12
years old. We accept the null hypothesis and reject the alternative hypothesis.
Table 7
Chi-Square Tests
Value df
Asymptotic significance (2-sided)
Pearson Chi-Square
9.479a 14
.799
Likelihood ratio
12.275 14
.584
Linear-by-linear association
1.201 1
.273
N of valid cases
157
a. 16 cells (66.7%) have expected count less than 5. The minimum expected count is
.01.
Table 8 shows the strength of the association between the amount of the
Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers among children
ages seven to 12 years old variables is weak by examining the phi and Cramer's V test.
Table 8
Symmetric Measures

Nominal by nominal
N of valid cases

Phi
Cramer's V

Approximate
Value
significance
.246
.799
.174
.799
157
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Research Question (RQ)2-Quantitative: What is the association between the
number of asthma episodes or attacks with or without professional inhalation
instruction on the proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in
children 7 to 12 years old?
The expected count is what I would expect to observe if there was no association.
In table 9 and figure 2, I would expect 340 children received professional inhaler
instruction, 11 did not receive professional inhaler instruction, and two children who did
not know if they received professional inhaler instruction with zero asthma episodes or
attacks. I would expect 100 children received professional inhaler instruction, three
children did not receive professional inhaler instruction, and 0.7 did not know if they
have received professional inhaler instruction with 1 number of asthma episodes or
attacks. I would expect 63 children received professional inhaler instruction, two did not
receive professional inhaler instruction, and 0.4 did not know if they have received
professional inhaler instruction with two asthma episodes or attacks. I would expect 28
children received professional inhaler instruction, 0.9 did not receive professional inhaler
instruction, and 0.2 did not know if they have received professional inhaler instruction
with three asthma episodes or attacks. I would expect 13 children received professional
inhaler instruction, 0.4 did not receive professional inhaler instruction, and 0.1 did not
know if they have received professional inhaler instructions who had four asthma
episodes or attacks. I would expect 14 children received professional inhaler instruction,
0.4 did not receive professional inhaler instruction, and 0.4 did not know if they have
received professional inhaler instruction, which had five asthma episodes or attacks. I
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would expect 12 children received professional inhaler instruction, 0.4 did not receive
professional inhaler instruction, and 0.1 did not know if they have received professional
inhaler instruction, which had six asthma episodes or attacks. I would expect five
children received professional inhaler instruction, 0.2 did not receive professional inhaler
instruction, and zero of the participants indicated that they do not know if they have
received professional inhaler instructions who had seven asthma episodes or attacks. I
would expect two children received professional inhaler instruction, 0.1 did not receive
professional inhaler instruction, and zero of the participants indicated that they do not
know if they have received a professional inhaler, which had eight asthma episodes or
attacks. I would expect one child received professional inhaler instruction, zero children
did not receive professional inhaler instruction, and zero of the participants indicated that
they do not know if they have received a professional inhaler, which had nine asthma
episodes or attacks. I would expect six children received professional inhaler instruction,
0.2 did not receive professional inhaler instruction, and zero of the participants indicated
that they do not know if they have received a professional inhaler, which had ten asthma
episodes or attacks. I would expect one child received professional inhaler instruction,
zero children did not receive professional inhaler instruction, and zero of the participants
indicated that they do not know if they have received professional inhaler instruction,
which had fifteen asthma episodes or attacks. I would expect three children received
professional inhaler instruction, 0.1 did not receive professional instruction, and zero of
the participants indicated that they do not know if they have received professional inhaler
instruction, which had twenty asthma episodes or attacks. I would expect two children
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received professional inhaler instruction, 0.1 did not receive professional inhaler
instruction, and zero of the participants indicated that they do not know if they have
received a professional inhaler instruction that had thirty asthma episodes or attacks. I
would expect one child received professional inhaler instruction; zero of the participants
did not receive professional instruction, and zero of the participants indicated that they do
not know if they have received professional inhaler instruction, which had forty asthma
episodes or attacks. I would expect one child received professional inhaler instruction;
zero of the participants did not receive professional instruction, and zero of the
participants indicated that they do not know if they have received professional inhaler
instruction, which had sixty asthma episodes or attacks. I would expect two children
received professional inhaler instruction, 0.1 did not receive professional inhaler
instruction, and zero of the participants indicated that they do not know if they have
received professional inhaler instruction, which had ninety asthma episodes or attacks.
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Table 9
The Number of Episodes or Attacks and Professional Inhaler Instruction

Professional inhaler instruction
Yes
Number of episodes/attacks

0

Count
Expected Count

1

Count
Expected Count

2

Count
Expected Count
Count

3
4

Expected Count
Count
Expected Count

5

Count
Expected Count

6

Count
Expected Count

7

Count
Expected Count

8

Count
Expected Count

9

Count
Expected Count

No

Don't know

Total

340

11

2

353

339.8

10.9

2.3

353.0

104

0

0

104

100.1

3.2

.7

104.0

62

3

0

65

62.6

2.0

.4

65.0

25

3

1

29

27.9

.9

.2

29.0

13

0

0

13

12.5

.4

.1

13.0

14

0

0

14

13.5

.4

.1

14.0

11

1

0

12

11.6

.4

.1

12.0

5

0

0

5

4.8

.2

.0

5.0

2

0

0

2

1.9

.1

.0

2.0

1

0

0

1

1.0

.0

.0

1.0

(table continues)
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Professional inhaler instruction
Yes
Number of episodes/attacks

10

Count

0

6

5.8

.2

.0

6.0

1

0

0

1

1.0

.0

.0

1.0

3

0

0

3

2.9

.1

.0

3.0

2

0

0

2

1.9

.1

.0

2.0

1

0

0

1

1.0

.0

.0

1.0

1

0

0

1

1.0

.0

.0

1.0

1

0

1

2

Expected Count

1.9

.1

.0

2.0

Count

591

19

4

614

591.0

19.0

4.0

614.0

Count

Count
Expected Count

30

Count
Expected Count

40

Count
Expected Count

60

Count
Expected Count

90

Total

Total

1

Expected Count
20

Don't know

5

Expected Count
15

No

Count

Expected Count
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Figure 2 shows a bar chart of the number of episodes or attacks and
whether the children received professional inhaler instruction.

Figure 2. The number of asthma episodes or attacks if a professional inhaler instruction
was provided.
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In table 10, the chi-square test, X2 = 95.541, p = .000. The statistical test tells us
that there is an association between the number of asthma episodes or attacks and with or
without a professional inhalation instruction on proper delivery of Albuterol (+ A. Sulfate
or Salbutamol) in children ages seven to 12 years old. We reject the null hypothesis and
accept the alternative hypothesis.
Table 10
Chi-Square Tests

Value df
Asymptotic significance (2-sided)
a
Pearson Chi-Square
95.541 32
.000
Likelihood ratio
27.806 32
.679
Linear-by-linear Association
39.926 1
.000
N of valid cases
614
a. 42 cells (82.4%) have expected count less than 5. The minimum expected count is
.01.
In table 11, we can see that the strength of the association between the number of
asthma episodes or attacks and with or without a professional inhalation instruction on
proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in children ages 7 to 12 years
old is strong by examining the phi and Cramer's V test.
Table 11
Symmetric Measures

Value Approximate significance
Nominal by nominal Phi
.394
.000
Cramer's V .279
.000
N of valid cases
614
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Summary
The first research question intends to investigate the association between the
amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers
among children ages seven to 12 years old. It was found that there is no significant
statistical association between the amount of the Albuterol (+ A. Sulfate or Salbutamol)
inhaled with or without spacers among children ages seven to 12 years old. Therefore, we
fail to reject the null hypothesis and reject the alternative hypothesis. The phi and
Cramer's V test indicated that the association between the variables is weak. The second
question intends to investigate the association between the number of asthma episodes or
attacks with or without a professional inhalation instruction on proper delivery of
Albuterol (+ A. Sulfate or Salbutamol) in children ages seven to 12 years old. The result
of this study showed that there is an association between the number of asthma episodes
or attacks and with or without a professional inhalation instruction on proper delivery of
Albuterol (+ A. Sulfate or Salbutamol) in children ages seven to 12 years old. Therefore,
we reject the null hypothesis and accept the alternative hypothesis. The phi and Cramer's
V test indicated that the association between the variables is strong. While section 3 has
demonstrated the statistical analysis findings, section 4 discussed the interpretation of the
findings in-depth, limitations of the study, and recommendations.
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Section 4: Application to Professional Practice and Implications for Social Change
Introduction
The primary purpose of this research study was to thoroughly investigate the
association between the amount of inhalation of Albuterol (+ A. Sulfate or Salbutamol),
whether or not using a spacer. I also examined the association between the number of
asthma episodes or attacks with or without professional inhalation instruction on the
proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in children 7 to 12 years old.
The nature of this study was a cross-sectional research design data analysis that was
conducted using Statistical Package for the Social Sciences (v.25) Software. Using
quantitative research for this study allowed me to develop numerical data that provided
in-depth information that supports generalizations related to the phenomenon under
study. I found that there is no significant statistical association between the amount of
Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers among children
ages 7 to 12. Additionally, I found that there is an association between the number of
asthma episodes or attacks with or without professional inhalation instruction on the
proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in children ages 7 to 12.
Interpretation of the Findings
The first research question tested the association between the amount of
inhalation of Albuterol (+ A. Sulfate or Salbutamol), whether using a spacer, in children
ages 7 to 12. The association between the amount of Albuterol (+ A. Sulfate or
Salbutamol) inhaled with or without spacers among children ages 7 to 12 was not
statistically significant (p > 0.05). The strength of association between the amount of
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Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers was weak based
on the phi and Cramer’s V test. Therefore, the number of doses inhaled in the lungs does
not depend on with or without a spacer. Previous studies have shown that using spacers
with an inhaler device is beneficial to improve drug delivery in the lungs as well as
prevent the medication from escaping in the air (Pessôa et al., 2018). A spacer is intended
to help the lungs absorb the appropriate amount of dose for effective treatment
(Farahbakhsh, 2020). However, the findings in this study do not align with the previous
studies. The findings of this study do not confirm whether using a spacer increases the
chance for the medication to be inhaled in the lungs.
The second research question tested the association between the number of
asthma episodes or attacks with or without professional inhalation instruction on the
proper delivery of Albuterol (+ A. Sulfate or Salbutamol) in children ages 7 to 12. The
association between the number of asthma episodes or attacks with or without
professional inhalation instruction on the proper delivery of Albuterol (+ A. Sulfate or
Salbutamol) in children ages 7 to 12 was statistically significant (p < 0.05). Phi and
Cramer’s test indicated that the strength of association between the number of asthma
episodes or attacks with or without professional inhalation instruction on the proper
delivery of Albuterol (+ A. Sulfate or Salbutamol) was strong. When children between
the ages of 7 and 12 receive professional inhaler instructions, they are more likely not to
have asthma episodes or attacks. The children may have fewer visits to the ED as a result
of this observation.
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On the other hand, if children do not receive professional inhaler instruction, they
may not know what to do during asthma episodes or attacks, and there is a higher
likelihood that they visit the ED for clinical evaluation and treatment. This result shows
the importance of receiving professional inhaler instruction to effectively manage asthma
to decrease the number of asthma episodes or attacks. The results imply a critical need for
children to learn the proper way to use an inhaler device to control their asthma
symptoms from a professional to reduce asthma episodes or attacks and ED visits. In
Table 9, (N = 340), children received professional inhaler instruction, which had 0 asthma
episodes or attacks. N = 1 indicated “yes” received professional inhaler instruction, N =
0.1 indicated “no” did not receive professional inhaler instruction, and N = 0.0 indicated
that children who “do not know” if they received professional inhaler instruction; they
had 90 asthma episodes or attacks.
The statistical test in Table 9 revealed that the more professional inhaler
instruction children received, the less they experienced asthma episodes or attacks. In
contrast, the children who did not receive professional inhaler instruction were more
likely to experience several asthma episodes or attacks. Previous studies revealed that the
effectiveness requires that patients use an inhalation device with a proper technique, and
health care providers must have firm skills to use inhalation devices in order to teach
their patients effectively (Kellman, Iserson, Levy, McIntosh, & Maxwell, 2020). Most
patients who visit the ED with asthma do not have adequate exposure to asthma
education (Losappio et al., 2019). However, the findings of my analysis in this study are
aligned with the literature in finding that the leading cause for children to visit the ED
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may occur due to not being able to operate an inhaler device properly when asthma
episodes or attacks happen.
Application of Transtheoretical Change or Stages of Change
The theoretical framework that was applied in this study was transtheoretical
change or stages of change. The transtheoretical change model was used to examine an
individual’s readiness to take action on a new behavior to improve their health. The
process of behavioral change involves five stages of change, including precontemplation,
contemplation, preparation, action, and termination (Keshmiri et al., 2017). Children
must be provided with relevant information by their parents or health care providers
about asthma and to recognize the symptoms of asthma to take actions to manage asthma
immediately effectively. Children must be educated and provided with guidance on the
proper use of an inhaler device for the sufficient amount of medication inhaled into the
lungs to reduce asthma episodes or attacks and ED visits. Based on the results of this
study, the transtheoretical model or stages of change imply that the children need to
understand the medical complications of asthma, and they must take the appropriate
actions. Changing their behavior may be essential to manage asthma effectively by firmly
adhering to the instructions on how to use inhaler devices to maximize the appropriate
amount of medication inhaled in the lungs to decrease the number of asthma episodes or
attacks.
Limitations of the Study
The limitations identified in this study included that the primary variables to test
for an association did not have values, and the variables associated in this study presented
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a large number of missing values as a sample of 176 was necessary. This factor may have
significantly affected the results as to whether there is an association between the amount
of the Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers among
children ages 7 to 12.
Recommendations
Further study is needed to conduct an in-depth exploration of how the age of a
child may influence the way they use an inhaler device properly, with or without a
spacer. There is a need for further research to identify a recommendable treatment plan
for a patient with asthma who has coronavirus disease 2019 (COVID-19). Researchers
need to further examine the efficacy of the interventions on managing asthma to help
reach the desired health outcome. There is a need for further investigation on whether
children are more likely to adhere to instructions provided by pharmacists and other
clinicians. For children who inhaled the appropriate amount of medication but do not
show improvement, it may be necessary to look at other factors, such as a history of
asthma or an underlying medical complication. It may also be necessary to research if
children are receiving information in their preferred learning style on how to use an
inhaler properly. Future researchers could also look at if children with a high number of
asthma attacks or episodes receive educational materials from their health care providers.
Researchers could also examine if the amount of medication inhaled in the lungs depends
on a spacer or medication with a built-in spacer without professional instruction. Another
future research question may be if it is more effective when a pharmacist provides
education on asthma management and the proper use of inhaler devices to a child rather
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than other clinicians. It may also be necessary to evaluate and focus on the asthma
treatment guidelines to align patient care at the policy level. There is a significant impact
when a pharmacist includes training on asthma control to children as they focus on the
asthma action plan and equip them with additional resources to better provide care for
children with asthma (Kovačević et al., 2018). Improperly using an inhaler medication
can lead to poor asthma management, leading to adverse outcomes. Deeks et al. (2018)
stated that pharmacists have demonstrated that they can improve asthma control by
increasing the appropriate use of medication.
Implications for Professional Practice and Social Change
Professional Practice
Clinics, hospitals, and pharmacies need to have current guidelines for managing
asthma. Professional clinicians should be competent and have broad knowledge about
asthma and the use of inhaler devices. Providers must commit to continuing education on
asthma to enhance their skills and expertise to implement the interventions for managing
asthma effectively. With minimal training, pharmacists would be able to perform a device
training educational session to all patients with asthma with the outcome of
improvements in asthma management (Basheti A., Salhi, Basheti M., Hamadi, & AlOerem, 2019). There is a confirmatory that poor inhaler technique contributes to poor
management and loss of asthma control with children requiring to take reliever
medications (Goodwin & Heraghty, 2015). There are at least 25% of children with
asthma who do not receive any verbal instructions on how to use their inhaler devices
sufficiently (Goodwin & Heraghty, 2015). For those who do, the quality and duration of
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instructions are often insufficient (Goodwin & Heraghty, 2015). All types of care
providers need to provide the highest quality care service to their inpatient and outpatient
children to ensure that expectations are met (Park, G., Park, K., & Agarwal, 2016). It may
be essential for clinical facilities to develop and implement some other ways to deliver
instructions on how to use inhaler devices correctly in children. The methods of teaching
aligned with children’s learning styles may increase their adherence to the guidelines
because they may have a better understanding of the whole sequence steps.
Social Change
The results of this study serve to develop a positive social change at an individual,
family, community, organization, and policy levels. The results transform into a positive
social change in human interactions as they become more aware of asthma and attain the
critical interventions to adhere to control asthma effectively. The parents and relatives
may become more aware of the problems that will increase their commitment to guiding
their children throughout the asthma treatment to improve symptoms. Additionally, the
parents and relatives will provide social support and commit to counseling their child
who has asthma by following the clinicians' guidelines to improve poor asthma outcomes.
The parents of children with asthma may also become a representative member of a
community to offer a forum to discuss the new insights found within the individuals at
large to encourage them to take action for the health improvement of their children with
asthma.
The results of this study signify the need for health policymakers to reevaluate
the guidelines of clinics to ensure that they stay current with the instructions for asthma
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management. Also, the clinics must ensure to be equipped with educational materials
about asthma that align with the needs of patients with asthma to maximize the efforts to
reach their desired health outcome. Ultimately, healthcare providers must take immediate
action after learning new insights about the importance of using inhaler devices correctly
to alleviate the number of children admitted to the ED or hospitalization rate.
Conclusion
Children with asthma remain to be a problem in the field of public health that
needs to mitigate. Asthma contributes to adverse health outcomes that limit a child’s
daily activities and even increase school absenteeism. An inhaler device is a standard
medication treatment for asthma with or without a spacer. A spacer is a tool that can be
attached to the inhaler device to help doses from escaping in the air, if operated correctly,
according to a previous study. This research found that there is no significant statistical
association between the amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled
with or without spacers among children ages seven to 12 years old when examining the
association between the amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled
with or without spacers among children ages seven to 12 years old. Additionally, this
study also investigated the association between the number of asthma episodes or attacks
and with or without a professional inhalation instruction on proper delivery of Albuterol
(+ A. Sulfate or Salbutamol) in children ages seven to 12 years old and it has found that
there is an association between the number of asthma episodes or attacks and with or
without a professional inhalation instruction on proper delivery of Albuterol (+ A. Sulfate
or Salbutamol) in children ages seven to 12 years old. The association between the
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amount of the Albuterol (+ A. Sulfate or Salbutamol) inhaled with or without spacers
among children ages seven to 12 years old was less clear. However, the statistical
significance between the number of asthma episodes or attacks with or without a
professional inhalation instruction on proper delivery of Albuterol (+ A. Sulfate or
Salbutamol) in children ages seven to 12 years old confirmed the findings from the
previous studies. When children do receive professional inhaler instructions, they are
most likely not to have asthma episodes or attacks, leading to fewer visits to the ED.
Subsequently, if children do not receive professional inhaler instruction, they are most
likely to not know what to do during asthma episodes or attacks. As a result, there is a
likelihood that they will visit the ED for treatment. This study of the phenomenon
warrants further research to deeply explore the effectiveness of the interventions for
controlling asthma as well as to investigate if there are other factors such as underlying
medical conditions that may prohibit the patients from recovering or worsening asthma
symptoms. The results of the study warrant a positive social change at an individual,
community, family, policy, and organizational levels to increase awareness and conduct
reevaluations of guidelines about the use of inhaler devices to improve asthma treatment
and management.
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